1. Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial. Issue 4 (April 2021) Authors: Lee, Nancy Y; Ferris, Robert L; Psyrri, Amanda; Haddad, Robert I; Tahara, Makoto; Bourhis, Jean; Harrington, Kevin; Chang, Peter Mu-Hsin; Lin, Jin-Ching; Razaq, Mohammad Abdul; Teixeira, Maria Margarida; Lövey, József; Chamois, Jerome; Rueda, Antonio; Hu, Chaosu; Dunn, Lara A; Dvorkin, Mikhail Vl... Journal: Lancet oncology Issue: Volume 22:Issue 4(2021) Page Start: 450 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing. Issue 1 (17th June 2020) Authors: Rischin, Danny; Migden, Michael R; Lim, Annette M; Schmults, Chrysalyne D; Khushalani, Nikhil I; Hughes, Brett G M; Schadendorf, Dirk; Dunn, Lara A; Hernandez-Aya, Leonel; Chang, Anne Lynn S; Modi, Badri; Hauschild, Axel; Ulrich, Claas; Eigentler, Thomas; Stein, Brian; Pavlick, Anna C; Geiger, Je... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗